When was Globela Pharma founded?

Globela Pharma was founded in 1996 and raised its 1st funding round 15 years after it was founded.

Where is Globela Pharma located?

Globela Pharma is headquartered in Surat, India. It is registered at Plot No. 357 - 358, Road No. 3 GIDC, Sachin, Vadodara, Surat, Gujarat, India, 394230.

Which legal entities is Globela Pharma associated with?

Globela Pharma is associated with GLOBELA PHARMA PRIVATE LIMITED and 2 others.

How many employees does Globela Pharma have?

As of Sep 30, 2024, Globela Pharma has 156 employees, reflecting a 7% year-over-year growth in headcount.

Is Globela Pharma a funded company?

Globela Pharma is a funded company, having raised a total of $11.4M across 3 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Mar 25, 2011.

How much is Globela Pharma worth?

The latest valuation of Globela Pharma is ₹***** as of Feb 17, 2022.

When was the latest funding round of Globela Pharma?

Globela Pharma's latest funding was a $***** Unattributed round on Jan 11, 2022, with participation from 3 investors.

What is the annual revenue of Globela Pharma?

Annual revenue of Globela Pharma is ₹296Cr as on Mar 31, 2025.

Where does Globela Pharma rank among its competitors?

Globela Pharma ranks 25th amongst 878 active competitors, of which 27 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Nivagen Pharmaceuticals, which secured $5M in Aug, 2023.

Who are the top competitors of Globela Pharma?

Globela Pharma's top competitors include Akums, Rubicon and Jubilant Life Sciences. Among them, Nivagen Pharmaceuticals secured the most recent funding round in August, 2023.

Globela Pharma - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Globela Pharma manufactures finished formulations such as tablets, capsules, syrup, and injectables. The products are of various therapeutic categories including antibiotics, analgesics, cardiovascular, anticancer, gastrointestinal, multivitamins, and others. The company has manufacturing facilities certified by ISO 9001: 2015 and WHO-GMP.

Website: globelapharma.com
Social
Email ID: *****@globelapharma.com
Phone Number: +91 **********, +91 **********
Registered Address: Plot No. 357 - 358, Road No. 3 GIDC, Sachin, Vadodara, Surat, Gujarat, India, 394230

Key Metrics

Founded Year

1996

Location

Surat, India

Stage

Early Stage

Total Funding

$11.4M in 3 rounds

Latest Funding Round

Unattributed, Jan 11, 2022, $*****

Post Money Valuation

₹***** as on Feb 17, 2022

Investors

Somerset Indus Capital Partners & 12 more

Ranked

25^th among 878 active competitors

Annual Revenue

₹296Cr as on Mar 31, 2025

Employee Count

156 as on Sep 30, 2024

Similar Companies

Akums & 1091 more

View Globela Pharma's full profile

Globela Pharma is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
Globela Biotech Llp CIN: AAR-6265 , India, Active	Jan 16, 2020	-	-
GLOBELA PHARMA PRIVATE LIMITED CIN: U24230GJ2006PTC047699 , India, Active	Feb 08, 2006	$35M (As on Mar 31, 2025)	148 (As on Dec 31, 2024)
GLOBELA LABORATORIES PRIVATE LIMITED CIN: U24304GJ2022PTC129637 , India, Active	Feb 24, 2022	$5.46M (As on Mar 31, 2025)	-

Globela Pharma has raised a total funding of $11.4M over 3 rounds. Its first funding round was on Mar 25, 2011. Its latest funding round was a Unattributed round on Jan 11, 2022 for $*****. 3 investors participated in its latest round. Globela Pharma has 2 institutional investors and 11 angel investors.

Here is the list of recent funding rounds of Globela Pharma:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 11, 2022	6453753	Unattributed	3377634	1025226	2331677	2855110
Sep 23, 2021	3685630	Unattributed	5333987	6905369	5386915	3528338
Mar 25, 2011	3333096	Unattributed	1239335	2830300	Rasik M Gondalia	Biren V Gondaliya & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Globela Pharma's funding rounds and investors

The founders of Globela Pharma is Priyank Vaghashia. Bhanu Vaghashia is the CEO of Globela Pharma.

Here are the details of Globela Pharma's key team members:

Priyank Vaghashia: Founder & COO of Globela Pharma.

Globela Pharma's Board of Directors

Globela Pharma's board has 5 active members. Bhanu Vaghashia and Urmila Bhanubhai Vaghashia are part of team and Rasik Gondalia, Ravi Shanker Kovi and Bhaskar Madhavray Savani are independent board members.

Here is the list of Globela Pharma's board of directors:

Name	Type	Representing	Status	Duration
nbenaxa	Team	-	Current	4y 9m
vppeqtz	Team	-	Current	5y 5m
Rasik Gondalia	Independent board member	-	Current	15y 2m
dnbbdda	Independent board member	-	Current	2y 7m
zrkes{p	Independent board member	-	Current	6y 8m
hol{sgq	Independent board member	-	Past	6y 7m

View details of Globela Pharma's Founder profiles and Board Members

Globela Pharma's employee count trend

Globela Pharma has 156 employees as of Sep 24. The total employee count is 7.0% more than what it was in Sep 23. Here is Globela Pharma's employee count trend over the years:

Uncover Globela Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Globela Pharma include Akums, Rubicon and Jubilant Life Sciences. Here is the list of Top 10 competitors of Globela Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital & 5 others	60/100
2nd	Rubicon 2000, Mumbai (India), Public	CDMO offering drug development services through its proprietary drug delivery technologies	$4.62M	Kotak Private Equity Group, Kotak Mahindra Bank ... & 3 others	60/100
3rd	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	Samena Capital, General Atlantic & 1 others	59/100
4th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	CPP Investments, Ampersand Capital	57/100
5th	Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired	Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution	$31M	Telegraph Hill Partners, BizCap & 1 others	56/100
6th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, NSR Partners & 1 others	56/100
7th	Ipca Laboratories 1949, Mumbai (India), Public	Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and generic medications	-	ChrysCapital	56/100
8th	SAVA group 2003, Pune (India), Unfunded	Pharma company with a portfolio of domestic and export products, also offering CRAMS services	-	-	56/100
9th	Supriya Lifescience 2008, Mumbai (India), Public	Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare	-	-	54/100
10th	Halo Pharma 2006, Hanover (United States), Acquired	CDMO offering integrated drug development services	$25M	Noramco, SK Capital	53/100
25th	Globela Pharma 1996, Surat (India), Early Stage	Manufacturer of tablets, capsules, syrup, and injectables	$11.4M	Somerset Indus Capital Partners, BIRAC & 11 others	48/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Globela Pharma's competitors? Click here to see the top ones

Founders (largest shareholder) own 55.62%, Funds own 17.91%, Angels own 3.44% and Other People own 23.03%. The net worth of Globela Pharma's founders is INR 213Cr as of Feb 17, 2022.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	55.62%	213Cr	8701549	6651219	5783935	2299879
Fund	17.91%	68.7Cr	3032233	2053236	2102804	3456040
Somerset Indus Capital Partners	5339697	9345719	1646872	6752969	8571373	7128450
Angel	3.44%	13.2Cr	422	222	996	516
Karthic Jayaraman	2	4	7	6	5	2
Rasik M Gondalia	0	0	0	0	0	0
Biren V Gondaliya	0	0	0	0	0	0
Other People	23.03%	88.3Cr	4359590	5369384	1881892	4896442
Total	100.00%	384Cr	1540428	6868930	7453746	6924048